Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Rifampin reduces oral morphine absorption: a case of transdermal buprenorphine selection based on morphine pharmacokinetics.

Fudin J, Fontenelle DV, Payne A.

J Pain Palliat Care Pharmacother. 2012 Dec;26(4):362-7. doi: 10.3109/15360288.2012.734903.

PMID:
23216174
2.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
3.

Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain.

Wolff RF, Aune D, Truyers C, Hernandez AV, Misso K, Riemsma R, Kleijnen J.

Curr Med Res Opin. 2012 May;28(5):833-45. doi: 10.1185/03007995.2012.678938. Epub 2012 Apr 25. Review.

PMID:
22443154
5.

Transdermal buprenorphine controls central neuropathic pain.

Weiner M, Sarantopoulos C, Gordon E.

J Opioid Manag. 2012 Nov-Dec;8(6):414-5. doi: 10.5055/jom.2012.0141.

PMID:
23264319
6.

Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.

Daitch J, Frey ME, Silver D, Mitnick C, Daitch D, Pergolizzi J Jr.

Pain Physician. 2012 Jul;15(3 Suppl):ES59-66.

7.

Buprenorphine in long-term control of chronic pain in cancer patients.

Pace MC, Passavanti MB, Grella E, Mazzariello L, Maisto M, Barbarisi M, Baccari E, Sansone P, Aurilio C.

Front Biosci. 2007 Jan 1;12:1291-9.

PMID:
17127381
8.

Loss of analgesic effect of morphine due to coadministration of rifampin.

Fromm MF, Eckhardt K, Li S, Schänzle G, Hofmann U, Mikus G, Eichelbaum M.

Pain. 1997 Aug;72(1-2):261-7.

PMID:
9272811
9.

Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients.

Freye E, Anderson-Hillemacher A, Ritzdorf I, Levy JV.

Pain Pract. 2007 Jun;7(2):123-9.

PMID:
17559481
10.

Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.

Mercadante S, Villari P, Ferrera P, Porzio G, Aielli F, Verna L, Casuccio A.

J Pain Symptom Manage. 2006 Aug;32(2):175-9.

PMID:
16877185
11.

Buprenorphine 5, 10 and 20 μg/h transdermal patch: a guide to its use in chronic non-malignant pain.

Plosker GL, Lyseng-Williamson KA.

CNS Drugs. 2012 Apr 1;26(4):367-73. doi: 10.2165/11208360-000000000-00000. Review.

PMID:
22369187
12.

Treatment of ischemic pain in patients suffering from peripheral vasculopathy with transdermal buprenorphine plus epidural morphine with ropivacaine vs. epidural morphine with ropivacaine.

Aurilio C, Pace MC, Passavanti MB, Paladini A, Maisto M, Iannotti M, Pota V, D'amora E, Sansone P, Barbarisi M.

Pain Pract. 2009 Mar-Apr;9(2):105-14. doi: 10.1111/j.1533-2500.2008.00237.x. Epub 2008 Sep 17.

PMID:
19019049
13.
14.

Transdermal buprenorphine (Butrans) for chronic pain.

[No authors listed]

Med Lett Drugs Ther. 2011 Apr 18;53(1362):31-2.

PMID:
21502936
15.
16.

Failure of pain control using transdermal fentanyl during rifampicin treatment.

Morii H, Chiba M, Konishi H, Endo Y, Yamaji A.

J Pain Symptom Manage. 2007 Jan;33(1):5-6. No abstract available.

PMID:
17196900
17.

Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.

Kharasch ED, Hoffer C, Whittington D, Sheffels P.

Clin Pharmacol Ther. 2003 Dec;74(6):543-54.

PMID:
14663457
18.

Transdermal buprenorphine.

Evans HC, Easthope SE.

Drugs. 2003;63(19):1999-2010; discussion 2011-2. Review.

PMID:
12962515
19.

Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.

Plosker GL.

Drugs. 2011 Dec 24;71(18):2491-509. doi: 10.2165/11208250-000000000-00000. Review.

PMID:
22141389
20.

Pediatric palliative care: use of opioids for the management of pain.

Zernikow B, Michel E, Craig F, Anderson BJ.

Paediatr Drugs. 2009;11(2):129-51. doi: 10.2165/00148581-200911020-00004. Review.

PMID:
19301934
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk